Back to results
US 11,299,486 B2Granted
Benzazole compounds and methods for making and using the compounds
AssigneeRigel Pharmaceuticals, Inc.
InventorsRose Yen, Yan Chen, Rajinder Singh, Vanessa Taylor
Life of this patent
Estimating the term…
Abstract
Disclosed are novel benzazole compounds and compositions comprising the compounds. The compounds are useful as kinase inhibitors including interleukin receptor associated kinases (IRAK) inhibitors. Also disclosed are methods of making and using the compounds and compositions. The disclosed compounds and/or compositions may be used to treat or prevent an IRAK-associated disease or condition.
Claims11
A method of treating a hematological malignancy in a subject, comprising administering to the subject an effective amount of a compound having a formula
- or a pharmaceutically acceptable salt thereof, wherein:
- X is O or S;
- Het-1 is heterocyclyl;
- R1 and R2 independently are H, aliphatic, heteroaliphatic, heterocyclyl, aryl, araliphatic, or together with the nitrogen to which they are attached, form a heterocyclic ring;
- R3, R4, R5, R6 and R9 independently are H, aliphatic, halo, heteroaliphatic, —O-aliphatic, heterocyclyl, aryl, araliphatic, —O-heterocyclyl, hydroxyl, nitro, cyano, carboxyl, carboxyl ester, acyl, amide, amino, sulfonyl, sulfonamide, sulfanyl, sulfinyl or haloalkyl;
- R7 is H, aliphatic, heteroaliphatic, heterocyclyl, aryl or araliphatic;
- each R8 independently is aliphatic, halo, heteroaliphatic, —O-aliphatic, heterocyclyl, aryl, araliphatic, —O-heterocyclyl, hydroxyl, nitro, cyano, carboxyl, carboxyl ester, acyl, amide, amino, sulfonyl, sulfonamide, sulfanyl, sulfinyl or haloalkyl;
- and
- m is from 0 to 3;
- wherein treating the hematological malignancy comprises slowing the development of the malignancy, stabilizing the malignancy, or causing regression of the malignancy or a symptom thereof.
7 more elements
Dependencies are inferred from the claim text.